Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0060
+0.0010 (20.00%)
At close: Jan 16, 2026
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $648.33 thousand as of January 16, 2026. Its market cap has decreased by -66.75% in one year.
Market Cap
648.33K
Enterprise Value
1.78M
Revenue
236.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 648.33K, a decrease of -96.71%. That is a compound annual growth rate of -25.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 648.33K | -18.92% |
| Dec 31, 2025 | 799.61K | -47.23% |
| Dec 31, 2024 | 1.52M | -57.47% |
| Dec 29, 2023 | 3.56M | -81.90% |
| Dec 30, 2022 | 19.69M | -70.55% |
| Dec 31, 2021 | 66.86M | 9,040.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 739.20M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 446.47M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 335.01M |
| Silence Therapeutics | 262.62M |